Covalon Technologies (CVE:COV) Trading 18.6% Higher

Covalon Technologies Ltd. (CVE:COV) shares were up 18.6% on Friday . The stock traded as high as C$1.15 and last traded at C$1.15. Approximately 10,000 shares were traded during mid-day trading, an increase of 73% from the average daily volume of 5,786 shares. The stock had previously closed at C$0.97.

Covalon Technologies Trading Up 18.6 %

The business has a 50 day simple moving average of C$1.24 and a two-hundred day simple moving average of C$1.18. The company has a current ratio of 4.81, a quick ratio of 6.45 and a debt-to-equity ratio of 7.79. The company has a market cap of C$28.37 million, a PE ratio of -6.05 and a beta of 0.55.

Covalon Technologies (CVE:COV) last released its earnings results on Wednesday, February 28th. The company reported C($0.03) EPS for the quarter. Covalon Technologies had a negative net margin of 19.67% and a negative return on equity of 23.98%. The business had revenue of C$4.66 million during the quarter. On average, analysts forecast that Covalon Technologies Ltd. will post 0.3 EPS for the current fiscal year.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.